Prevalence and Associated Factors of Neurocognitive Impairment in HIV-Positive Patients on Effective Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate Treatment

被引：0
|
作者：
Giancola, Maria Letizia [1 ]
Balestra, Pietro [1 ]
Ammassari, Adriana [1 ]
Ricottini, Martina [1 ]
Lorenzini, Patrizia [1 ]
Angeletti, Claudio [1 ]
Bellagamba, Rita [1 ]
Tommasi, Chiara [1 ]
Tempestilli, Massimo [1 ]
Zaccarelli, Mauro [1 ]
Pinnetti, Carmela [1 ]
Gallo, Anna Loredana [1 ]
Antinori, Andrea [1 ]
Narciso, Pasquale [1 ]
Nicastri, Emanuele [1 ]
机构：
[1] IRCCS, Natl Inst Infect Dis Lazzaro Spallanzani, Via Portuense 292, Rome, Italy
来源：
AIDS RESEARCH AND HUMAN RETROVIRUSES | 2018年 / 34卷 / 11期
关键词：
HIV; neurocognitive impairment; neuropsychological examination; cART; efavirenz;
D O I：
10.1089/aid.2018.0074
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：907 / 908
页数：2
相关论文
共 50 条
  • [1] Combination Therapy Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate Associated with Hepatic Failure
    Qayyum, Sohail
    Dong, Huijun
    Kovacic, Dianne
    Sohail, Sidra
    Waters, Bradford
    Thornton, Camille
    Corbett, Cathy E.
    [J]. CURRENT DRUG SAFETY, 2012, 7 (05) : 391 - 393
  • [2] Therapeutic drug monitoring study on the switch from coformulated 600-mg efavirenz, tenofovir disoproxil fumarate, and emtricitabine to coformulated 400-mg efavirenz, tenofovir disoproxil fumarate, and lamivudine among HIV-positive patients with viral suppression
    Huang, Wei-Chieh
    Huang, Chun-Kai
    Huang, Sung-Hsi
    Lin, Shu-Wen
    Ou, Shyh-Tyan
    Chen, Yi-Ting
    Chen, Ya-Wen
    Chang, Shu-Yuan
    Liu, Wen-Chun
    Sun, Hsin-Yun
    Hung, Chien-Ching
    [J]. JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION, 2021, 54 (05) : 944 - 951
  • [3] The predicted risk of adverse pregnancy outcomes as a result of treatment-associated obesity in a hypothetical population receiving tenofovir alafenamide/emtricitabine/dolutegravir, tenofovir disoproxil fumarate/emtricitabine/dolutegravir or tenofovir disoproxil fumarate/emtricitabine/efavirenz
    Asif, Sumbul
    Baxevanidi, Evangelia
    Hill, Andrew
    Venter, Willem Daniel Francois
    Fairlie, Lee
    Masenya, Masebole
    Serenata, Celicia
    Sokhela, Simiso
    Chandiwana, Nomathemba
    [J]. AIDS, 2021, 35 : S117 - S125
  • [4] Randomized, phase 2 evaluation of two single-tablet regimens elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate versus efavirenz/emtricitabine/tenofovir disoproxil fumarate for the initial treatment of HIV infection
    Cohen, Calvin
    Elion, Richard
    Ruane, Peter
    Shamblaw, David
    DeJesus, Edwin
    Rashbaum, Bruce
    Chuck, Steven L.
    Yale, Kitty
    Liu, Hui C.
    Warren, David R.
    Ramanathan, Srinivasan
    Kearney, Brian P.
    [J]. AIDS, 2011, 25 (06) : F7 - F12
  • [5] Systematic review of renal and bone safety of the antiretroviral regimen efavirenz, emtricitabine, and tenofovir disoproxil fumarate in patients with HIV infection
    Bedimo, Roger
    Rosenblatt, Lisa
    Myers, Joel
    [J]. HIV CLINICAL TRIALS, 2016, 17 (06): : 246 - 266
  • [6] Use of tenofovir disoproxil fumarate and emtricitabine combination in HIV-infected patients
    Gazzard, BG
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2006, 7 (06) : 793 - 802
  • [7] Week 48 results from a randomized clinical trial of rilpivirine/emtricitabine/tenofovir disoproxil fumarate vs. efavirenz/emtricitabine/tenofovir disoproxil fumarate in treatment-naive HIV-1-infected adults
    Cohen, Calvin
    Wohl, David
    Arribas, Jose R.
    Henry, Keith
    Van Lunzen, Jan
    Bloch, Mark
    Towner, William
    Wilkins, Edmund
    Ebrahimi, Ramin
    Porter, Danielle
    White, Kirsten
    Walker, Ivan
    Chuck, Susan
    De-Oertel, Shampa
    Fralich, Todd
    [J]. AIDS, 2014, 28 (07) : 989 - 997
  • [8] Tenofovir disoproxil fumarate, emtricitabine, and efavirenz compared with zidovudine/lamivudine and efavirenz in treatment-naive patients - 144-week analysis
    Arribas, Jose R.
    Pozniak, Anton L.
    Gallant, Joel E.
    DeJesus, Edwin
    Gazzard, Brian
    Campo, Rafael E.
    Chen, Shan-Shan
    McColl, Damian
    Holmes, Charles B.
    Enejosa, Jeffrey
    Toole, John J.
    Cheng, Andrew K.
    [J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2008, 47 (01) : 74 - 78
  • [9] Associations with HIV-related symptoms and weight change after switching from efavirenz/emtricitabine/tenofovir disoproxil fumarate to bictegravir/emtricitabine/tenofovir alafenamide
    Lowman, E.
    Hardigan, P.
    Unger, N.
    Lee, N.
    [J]. JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2020, 23 : 75 - 75
  • [10] A Randomized Double-Blind Comparison of Coformulated Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate Versus Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate for Initial Treatment of HIV-1 Infection: Analysis of Week 96 Results
    Zolopa, Andrew
    Sax, Paul E.
    DeJesus, Edwin
    Mills, Anthony
    Cohen, Calvin
    Wohl, David
    Gallant, Joel E.
    Liu, Hui C.
    Plummer, Andrew
    White, Kirsten L.
    Cheng, Andrew K.
    Rhee, Martin S.
    Szwarcberg, Javier
    [J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2013, 63 (01) : 96 - 100
12345